MedTrace Logo

The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes

NCT03106311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-07-11

No results posted yet for this study

Summary

Two groups will be recruited. The first group are pregnant ladies that have unequivocal rupture of fetal membranes that is diagnosed by seeing the amniotic fluid leakage in the vagina. The second group are normal pregnant ladies without rupture of membranes. both groups will be tested by taking vaginal washing fluid. Quantitative and qualitative pregnancy tests will be measured in this fluid.

Conditions

  • Premature Rupture of Membrane

Interventions

DIAGNOSTIC_TEST

assessment of beta subunit of human chorionic gonadotropin

Vaginal washing fluid will be collected and sent for measurement of beta subunit of human chorionic gonadotropin

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Eman Omran, M.D. · Cairo University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2017-06-29
Completion
2017-07-07

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03106311 on ClinicalTrials.gov